RARE DISEASERESEARCH ATLAS

ORPHA:2695

Bifid nose

medium confidenceDisorder

Publications

237

67.5th percentile

Trials

0

Interventional, condition-specific

Researchers

1,227

Distinct authors in sample

Gene link

Readiness

1/6

Stages with a signal

Clinical definition (Orphanet)

A rare nose and cavum anomaly characterized by clefting of the nose ranging from a minimally noticeable groove in the columella to complete clefting of the underlying bones and cartilage (resulting in two half noses) with a usually adequate airway. Bifid nose may be seen in frontonasal ; other malformations such as hypertelorbitism and midline clefts of the lip may also be associated.

How rare: How common this is has not been clearly measured.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

1/6 stages with a signal

Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    237 matched papers (106 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

237

237 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

237 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

106 in the last 10 years · medium confidence · 67.5th percentile (publications denominator)

Phrase hits: 237 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,227

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Dai C5 papers · 2024

    Shanghai Jiao Tong university medical college, Ninth people's hospital, PR China; Department of Plastic & Reconstructive Surgery, The Ninth affiliated Hospital of Shanghai Jiaotong Medicine University. 639 Zhi Zao Ju Rd. Shanghai, 200011 PR China. Electronic address: drweijiao@hotmail.com.

    Papers in Europe PMC
  2. 02
    Scott DA5 papers · 2022

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.

    Papers in Europe PMC
  3. 03
    Wang X5 papers · 2026

    Department of Obstetrics, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, China.

    Papers in Europe PMC
  4. 04
    Wei J5 papers · 2024

    Shanghai Jiao Tong university medical college, Ninth people's hospital, PR China; Department of Plastic & Reconstructive Surgery, The Ninth affiliated Hospital of Shanghai Jiaotong Medicine University. 639 Zhi Zao Ju Rd. Shanghai, 200011 PR China.

    Papers in Europe PMC
  5. 05
    Yu B5 papers · 2024

    Shanghai Jiao Tong university medical college, Ninth people's hospital, PR China; Department of Plastic & Reconstructive Surgery, The Ninth affiliated Hospital of Shanghai Jiaotong Medicine University. 639 Zhi Zao Ju Rd. Shanghai, 200011 PR China.

    Papers in Europe PMC
  6. 06
    Chen X4 papers · 2024

    Shanghai Jiao Tong university medical college, Ninth people's hospital, PR China; Department of Plastic & Reconstructive Surgery, The Ninth affiliated Hospital of Shanghai Jiaotong Medicine University. 639 Zhi Zao Ju Rd. Shanghai, 200011 PR China.

    Papers in Europe PMC
  7. 07
    Li D4 papers · 2025

    Department of Ophthalmology, Beijing Tongren Hospital, Beijing Ophthalmology and Visual Science Key Lab, Capital Medical University, No.1 Dong Jiao Min Xiang Street, Dongcheng District, Beijing, 100730, China. ldmlily@x263.net.

    Papers in Europe PMC
  8. 08
    Liu Y4 papers · 2026

    Institute for Pediatric Regenerative Medicine of Shriners Hospitals for Children, School of Medicine, University of California at Davis, Sacramento, California, USA.

    Papers in Europe PMC
  9. 09
    Wang H4 papers · 2023

    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510623, China.

    Papers in Europe PMC
  10. 10
    Wang Z4 papers · 2024

    Department of Urology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

medium confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Bifid nose"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Bifid nose"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is short or not clearly distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-26T20:52:27.373Z